Prime Medicine, Inc.
PRME
$1.24
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 944.50% | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 944.50% | -- | |||
| Cost of Revenue | -15.46% | -6.34% | |||
| Gross Profit | 20.46% | 6.83% | |||
| SG&A Expenses | -12.77% | 11.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.76% | -2.21% | |||
| Operating Income | 18.46% | 2.59% | |||
| Income Before Tax | 19.50% | 5.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 19.50% | 5.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.50% | 5.08% | |||
| EBIT | 18.46% | 2.59% | |||
| EBITDA | 19.31% | 2.70% | |||
| EPS Basic | 26.36% | 5.54% | |||
| Normalized Basic EPS | 27.23% | 3.02% | |||
| EPS Diluted | 26.36% | 5.54% | |||
| Normalized Diluted EPS | 27.23% | 3.02% | |||
| Average Basic Shares Outstanding | 9.32% | 0.48% | |||
| Average Diluted Shares Outstanding | 9.32% | 0.48% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||